Amicus Therapeutics Provides Full-Year 2013 Financial Guidance and Strategic Outlook

[at noodls] – 6-Month (Stage 1) Results from Ongoing Phase 3 Fabry Disease Monotherapy Study at Lysosomal Storage Disease Network WORLD Symposium (LDN WORLD) in February 2013; 12-Month Results Expected in 2Q13 Pompe, … more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view